ITM Isotopen Technologien München
2004
FOUNDED
PRIVATE
STATUS
41-50
EMPLOYEES
PE Growth
LATEST DEAL TYPE
4
FINANCING ROUNDS
Description
Developer of novel radiopharmaceuticals and radiomedical devices. The company design and develops novel radiopharmaceuticals and radiomedical devices. The company products are rhenium-SCT for non-invasive skin cancer therapy and ITM rhenium-PTA/PTCA for endovascular brachytherapy.
Ownership Status
Privately Held (backing)
Financing Status
Private Equity-Backed
Primary Industry
Diagnostic Equipment
Other Industries
Therapeutic Devices
Surgical Devices
Primary Office
- Lichtenbergstraße 1
- 85748 Munich
- Germany
+49 089 0000000000
ITM Isotopen Technologien München Valuation and Funding
| Deal Type | Date | Amount | Post-Val | Valuation/ EBITDA |
Debt | Status |
|---|
This information is reserved for PitchBook Platform users. To explore ITM Isotopen Technologien München‘s full profile, request access.
Request full access to PitchBookITM Isotopen Technologien München Investors
| Investor Name | Investor Type | Holding | Participating Rounds | Investor Since | Board Seat | Contact Info |
|---|
This information is reserved for PitchBook Platform users. To explore ITM Isotopen Technologien München‘s full profile, request access.
Request full access to PitchBookITM Isotopen Technologien München Executive Team (5)
ITM Isotopen Technologien München Board Members (1)
| Name | Representing | Role | Since | Contact Info |
|---|---|---|---|---|
| 0000000 00000000 | ITM Isotopen Technologien München | Chief Executive Officer & Chairman | 000 0000 |